Clinical Trial Update: Study to Investigate the Efficacy and Safety of Dupilumab in Pediatric Patients With Active Eosinophilic Esophagitis (EoE) [Phase 3]

View source ↗

Summary

Phase 3 study evaluating dupilumab in pediatric patients with active eosinophilic esophagitis has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Esophagitis

Drugs mentioned

• Dupilumab (dupilumab)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Eosinophilic Esophagitis (EoE) | Phase 3 | Status: COMPLETED | Results posted: 2024-08-27